Pathophysiological processes and possible therapeutical strategies in neurodegeneration models. Clinical and basic studies
Year: 1978
Type: dissertation
Abstract: Study background: Alzheimer’s (AD) and Parkinson’s Disease (PD) represent the \nmost frequent clinical expressions of neurodegeneration. \nGreat genetic heterogeneity characterizes neurodegenerative diseases: there are \ncases with Mendelian transmission and complete penetrance, and others in which \ngenetics predispose to greater disease susceptibility. In this scenery, the influence of \nenvironmental factors plays a fundamental role in contributing to disease development. \nThe increasing focus on genetic etiology of diseases over the past 20 years has \nresulted in a significant body of knowledge for neurological pathologies, providing great \ninsight not only into the role of genetics in sporadic PD, but also into the molecular \npathways and disease mechanisms involved in the pathogenesis. \nAD wise, positional cloning led to the identification of rare, disease-causing \nmutations in APP, PSEN1, and PSEN2 responsible for early-onset familial AD, followed \nby the discovery of APOE as the single most important risk factor for late-onset AD. It is \nhowever interesting how during the course of only three years, genome-wide association \nstudies (GWAS) in AD have yielded more reproducible, consistent and thus likely more \nrelevant findings than three decades of candidate-gene-driven research. Recent GWAS \nhave delivered several additional AD susceptibility loci that are common in the general \npopulation, but exert only very small risk effects. As a result, a large proportion of the \nheritability of AD continues to remain unexplained by the currently known disease genes. \nProject 1: Genome-wise association study - Genetic Park Project Friuli Venezia Giulia \nThe first study, whose core is the whole genome analysis, involves all inhabitants \nof six isolated populations of Friuli Venezia-Giulia. \nPotentially, it offers a powerful opportunity for evaluating and understanding the \nrelative contribution of genes and environment in the development of complex or \nmultifactorial diseases, including AD. Research performed in isolated populations might \noffer unique information, thanks to favourable characteristics such as reduced genetic \nheterogeneity secondary to “founder effect” and endogamia, and greater environmental \nuniformity, as compared with large continental populations. \nThis study can be subdivided into three phases: 1) data collection of possible risk \nfactors, family recurrence and personal history of cognitive impairment; 2) brief \nneurological and neuropsychological screening, aiming at identification of possible AD \ncases (NINDS-ADRDA criteria); 3) blood collection and genome analysis in the group of \nsubjects with clinical suspicion of AD with/without cerebrovascular disease. \nEpidemiological data analysis evidenced greater dementia prevalence in isolated \npopulations if compared to prevalence in Italian population (9% versus 5%, in people \n>65 years). After whole genome analysis and comparisons of genetic data of healthy \nand affected subjects, possible correlations between dementia and some specific risk \nfactors (low education, atrial fibrillation and diabetes) have been found. \nFinally, Genome Wise Association Study found a really interesting gene \ndifferently expressed in demented patients: PTPRD gene on chromosome 9, that is \nalready know to play an important role in Long Term Potentiation mechanisms in mice. \nTo our knowledge, this is the first report of possible PTPRD involvement in humans with \ncognitive decline, and the first from GWAS to be somehow not related to A! hypothesis. \nProject 2: Gene expression profiling in de novo Parkinson’s Disease patients \nThis study intends to analyze gene expression profiling in patients with a clinical \ndiagnosis of PD, confirmed by DaTSCAN, naïve from any specific therapy, in order to \nfind out potential biomarkers for PD, easily detectable in peripheral blood through noninvasive \nmethods, and possibly allowing a pre-clinical diagnosis. \nWe performed a transcriptome-wide scan in 40 idiopatic PD patients, looking for \nmolecular processes alteration in their blood cells, and comparing the results with those \nof 20 healthy controls, matched for age, sex and environmental factors. \nAfter clinical diagnosis and instrumental confirmation of PD, the experimental \ndesign includes RNA isolation from venous whole blood, microarray analysis, data \nprocessing, Real-Time PCR, functional classification process. \nAccording to preliminary results of gene expression profiling in PD patients, some \nspecific pathways seem to be related to PD pathological processes, in particular: \nhypoxia, axonal guidance, calcium signaling, inflammation, diabetes, glycosphingolipid \nmetabolism, neurotransmitters pathways, neurodegenerative diseases. \nFurther studies and replication of these findings are obviously mandatory for their \nvalidation, but we think this could be a starting point for understanding \nphysiopathological mechanisms and developing new therapeutical strategies in PD. \n"
Author: Tatiana Cattaruzza
Institution: University of Trieste
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, Parkinson's disease, neurodegeneration, genetic susceptibility, genome-wide association study, isolated populations, founder effect, endogamy, apolipoprotein E, APP, presenilin 1, presenilin 2, genetic heterogeneity, environmental risk factors, cognitive impairment, neurodegeneration model, treatment options, neuroprotection, neuroinflammation, neurodegeneration biomarkers
Open Access status: green
OpenAlex ID: W1537370797
